By blocking NOS activity, NOS inhibitors reduce S-nitrosylation levels on critical signaling proteins, thereby destabilizing ERK phosphorylation and amplifying the suppressive effects of MEK inhibitors on tumor growth. Here, MAP2K7 is linked to neoplasm.